Company Filing History:
Years Active: 2024
Title: Dorte M K Klitgaard: Innovating in Serine Protease Variants
Introduction: Dorte M K Klitgaard, an accomplished inventor based in Bagsvaerd, Denmark, has contributed significantly to the field of biochemistry through her innovative research on serine protease variants. With one patent to her name, she has developed solutions that enhance the properties of these enzymes, paving the way for advancements in biotechnology.
Latest Patents: Dorte's most notable patent is titled "Serine protease variants and polynucleotides encoding same." This invention centers around the creation of serine protease variants that demonstrate improved characteristics compared to the parent protease. Specifically, these variants exhibit increased stability, enhanced thermo-stability, elevated specific activity, and higher expression levels. The patent also encompasses polynucleotides encoding the variants, along with nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides. This advancement has far-reaching implications in various applications, particularly in industrial processes where robust enzymes are of necessity.
Career Highlights: Dorte M K Klitgaard is currently associated with Novozymes A/S, a global leader in biotechnology, focusing on enzyme and microbial solutions. Her work at this esteemed company highlights her commitment to developing innovative biotechnological solutions that address specific industrial needs.
Collaborations: Throughout her career, Dorte has worked alongside notable colleagues such as Roland Alexander Pache and Martin Gudman. This collaboration reflects her commitment to engaging with other experts in the field, promoting a spirit of teamwork and shared knowledge that drives innovation forward.
Conclusion: Dorte M K Klitgaard exemplifies the spirit of innovation in the realm of biochemistry, particularly through her work with serine proteases. Her patent serves as a testament to her dedication to enhancing enzyme properties, ultimately contributing to advancements in biotechnology. As she continues her work at Novozymes A/S, her research promises to unlock new potentials in the field, encouraging further innovation and collaboration.